EVEROLIMUS MSDS PDF

Acute toxicity: oral toxicity (LD50): > mg/kg (mouse), > mg/kg (rat) – toxicity data from the Abbott Vascular MSDS dated January 16, for Everolimus. SAFETY DATA SHEET. (in accordance with Regulation (EU) /). Everolimus. Version: 1. Revision date: 29/06/ Page 1 of. Material Safety Data Sheet. Section 1 – Product and Company Information. Product Name: Everolimus. Cat. Code: tlrl-eve. Company identification: InvivoGen.

Author: Fegul Vudocage
Country: Zimbabwe
Language: English (Spanish)
Genre: Education
Published (Last): 16 November 2007
Pages: 193
PDF File Size: 2.81 Mb
ePub File Size: 13.60 Mb
ISBN: 855-7-99162-839-7
Downloads: 90099
Price: Free* [*Free Regsitration Required]
Uploader: Fauzilkree

Insulin Detemir The therapeutic efficacy of Insulin Detemir can be evdrolimus when used in combination with Everolimus. Peginterferon beta-1a The risk or severity of adverse effects can be increased when Everolimus is combined with Peginterferon beta-1a.

Should consult the doctor for advice if you want to or has become pregnant. Copanlisib The metabolism of Everolimus can be decreased when combined with Copanlisib. Dexamethasone The metabolism of Everolimus mss be increased when combined with Dexamethasone. Cefradine The metabolism of Everolimus can be increased when combined with Cefradine. Atovaquone The metabolism of Everolimus can be decreased when combined with Atovaquone.

Everolimus

Use adequate general or local exhaust ventilation to keep airborne concentrations below the permissible exposure limits. Gallium nitrate The risk or severity of adverse effects can be increased when Everolimus is combined with Gallium nitrate.

  CORRADO ETKA PDF

Interferon alfacon-1 The everolimuss or severity of adverse effects can be increased when Interferon alfacon-1 is combined with Everolimus.

Carbinoxamine The metabolism of Everolimus can be decreased when combined with Carbinoxamine.

Etynodiol The metabolism of Everolimus can be decreased when combined with Etynodiol. Artesunate The metabolism of Everolimus can be decreased when combined with Artesunate.

Ethyl biscoumacetate The metabolism of Ethyl biscoumacetate everoimus be decreased when combined with Everolimus. Dofequidar The serum concentration of Everolimus can be increased when it is combined with Dofequidar. Nilvadipine The metabolism of Everolimus can be decreased when combined with Nilvadipine.

Lisuride The metabolism of Everolimus can be decreased when combined with Lisuride.

Interferon Alfa-2a, Recombinant The risk or severity of adverse effects can be increased when Interferon Alfa-2a, Recombinant is combined with Everolimus. Methyltestosterone The metabolism of Everolimus can be decreased when combined with Methyltestosterone. Flupentixol The serum concentration of Everolimus can be increased when it is combined with Flupentixol. Chlorambucil The risk or severity of everolkmus effects can be increased when Chlorambucil is combined with Everolimus.

Darexaban The risk or severity of bleeding can be increased when Darexaban is combined with Everolimus. Atrasentan The excretion of Atrasentan can be decreased when combined with Everolimus.

Everolimus | C53H83NO14 – PubChem

Isosorbide dinitrate The metabolism of Everolimus can be decreased when combined with Isosorbide dinitrate. Immediately flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids.

  DAVIDX EBOOK PDF

Dofetilide The metabolism of Everolimus can be decreased when combined with Dofetilide.

Dacomitinib The serum concentration of Everolimus can be increased when it is combined with Dacomitinib. Bacillus calmette-guerin substrain connaught live antigen The risk or severity of infection can be increased when Bacillus calmette-guerin substrain connaught live antigen is combined with Everolimus.

Canakinumab Everolkmus risk or severity of adverse effects can be increased when Everolimus is combined with Canakinumab.

Megestrol acetate The serum concentration of Everolimus can be increased when it is combined with Megestrol acetate. Debrisoquin The serum concentration of Debrisoquin can be increased when it is combined with Everolimus. Glasdegib The metabolism of Everolimus can be decreased when combined with Glasdegib.

Midazolam The serum concentration of Everolimus can be increased when it is combined with Midazolam. Hydrocortamate The metabolism of Everolimus can be increased when combined with Hydrocortamate. Epofolate The metabolism of Everolimus can be decreased when combined with Epofolate.

Dunn, C, and K.